Elisa Sicuri is Assistant Professorial Research Fellow (0.5 FTE) of Health Economics working on DIAGMAL project. She also holds a position (0.5 FTE) as Associate Research Professor at the Barcelona Institute for Global Health (ISGlobal).
Dr Sicuri works on health economics in low- and middle-income countries. Her research focuses on the economics of infectious diseases, particularly of neglected tropical diseases/vector-borne diseases, and includes a range of studies: cost-effectiveness/cost-benefit analysis of health interventions, analysis of the market for health products and impact evaluation of infectious diseases (interventions) on economic indicators.
With funding from the European Commission (H2020 programme) and from the European and Developing CountriesClinical Trials Partnership Programme, she is currently leading the economic workstreams of a number of large projects, including “Vaccine for prevention and treatment of Trypanosoma cruzi infection (CRUZIVAX)”, “Fast and reliable easy-to-use diagnostics for eliminating Bilharzia in young children and mothers (FreeBILy)” and “Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic (ORCHESTRA)” among others. She is also contributing to the health economics workstreams of the H2020 studies “Prevention and management tools for reducing antibiotic resistance in high prevalence settings (REVERSE)” and “Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE)” projects.
Associate Research Professor, Barcelona Institute for Global Health (ISGlobal)
Associate Professor, Faculty of Medicine, University of Barcelona
Associate Researcher, Centre d’Économie de la Sorbonne, Université Paris 1-Pantheon Sorbonne
Member of the Drugs for Neglected Diseases initiative (DNDi) Access Committee